FDA.reportPublic FDA data

200 ML immunoglobulin G, human 100 MG/ML Injection [Privigen]

RxCUI
1809520
RxNorm name
200 ML immunoglobulin G, human 100 MG/ML Injection [Privigen]
Display name
200 ML immunoglobulin G, human 100 MG/ML Injection [Privigen]
Full name
200 ML immunoglobulin G, human 100 MG/ML Injection [Privigen]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125201PrivigenImmune Globulin Intravenous (Human), 10% Liquid351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7e5649da-75be-4a42-8eeb-4aeba562c401privigen 10 % in 200 ML Injection [PSN] · 200 ML immunoglobulin G, human 100 MG/ML Injection [Privigen] [SBD] · 200 ML Privigen 100 MG/ML Injection [SY] · Privigen 10 % per 200 ML Injection [SY] · Privigen 20 GM per 200 ML Injection [SY]529These highlights do not include all the information needed to use PRIVIGEN safely and effectively. See full prescribing information for PRIVIGEN. PRIVIGEN, Immune Globulin Intravenous (Human), 10% Liquid, for intravenous use Initial U.S. Approval: 200720260504